|
|
Overexpressed long noncoding RNA CRNDE with distinct alternatively spliced isoforms in multiple cancers |
Xuefei Ma1, Wei Zhang1,2, Rong Zhang3, Jingming Li1, Shufen Li1, Yunlin Ma1, Wen Jin1(), Kankan Wang1,2() |
1. State Key Laboratory of Medical Genomics and Shanghai Institute of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China 2. School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China 3. Department of Hematology, Xi’an Gaoxin Hospital, Xi’an 710075, China |
|
|
Abstract Alternative splicing is a tightly regulated process that contributes to cancer development. CRNDE is a long noncoding RNA with alternative splicing and is implicated in the pathogenesis of several cancers. However, whether deregulated expression of CRNDE is common and which isoforms are mainly involved in cancers remain unclear. In this study, we report that CRNDE is aberrantly expressed in the majority of solid and hematopoietic malignancies. The investigation of CRNDE expression in normal samples revealed that CRNDE was expressed in a tissue- and cell-specific manner. Further comparison of CRNDE expression in 2938 patient samples from 15 solid and hematopoietic tumors showed that CRNDE was significantly overexpressed in 11 malignancies, including 3 reported and 8 unreported, and also implicated that the overexpressed isoforms differed in various cancer types. Furthermore, anti-cancer drugs could efficiently repress CRNDE overexpression in cancer cell lines and primary samples, and even had different impacts on the expression of CRNDE isoforms. Finally, experimental profiles of 12 alternatively spliced isoforms demonstrated that the spliced variant CRNDE-g was the most highly expressed isoform in multiple cancer types. Collectively, our results emphasize the cancer-associated feature of CRNDE and its spliced isoforms, and may provide promising targets for cancer diagnosis and therapy.
|
Keywords
long noncoding RNA
CRNDE
alternative splicing
|
Corresponding Author(s):
Wen Jin,Kankan Wang
|
Just Accepted Date: 12 February 2018
Online First Date: 29 May 2018
Issue Date: 05 June 2019
|
|
1 |
Z Zhang, S Pal, Y Bi, J Tchou, RV Davuluri. Isoform level expression profiles provide better cancer signatures than gene level expression profiles. Genome Med 2013; 5(4): 33
https://doi.org/10.1186/gm437
pmid: 23594586
|
2 |
K Miura, W Fujibuchi, M Unno. Splice isoforms as therapeutic targets for colorectal cancer. Carcinogenesis 2012; 33(12): 2311–2319
https://doi.org/10.1093/carcin/bgs347
pmid: 23118106
|
3 |
P Gellert, Y Ponomareva, T Braun, S Uchida. Noncoder: a web interface for exon array-based detection of long non-coding RNAs. Nucleic Acids Res 2013; 41(1): e20
https://doi.org/10.1093/nar/gks877
pmid: 23012263
|
4 |
JE Wilusz, H Sunwoo, DL Spector. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 2009; 23(13): 1494–1504
https://doi.org/10.1101/gad.1800909
pmid: 19571179
|
5 |
AE Kornienko, CP Dotter, PM Guenzl, H Gisslinger, B Gisslinger, C Cleary, R Kralovics, FM Pauler, DP Barlow. Long non-coding RNAs display higher natural expression variation than protein-coding genes in healthy humans. Genome Biol 2016; 17(1): 14
https://doi.org/10.1186/s13059-016-0873-8
pmid: 26821746
|
6 |
RA Gupta, N Shah, KC Wang, J Kim, HM Horlings, DJ Wong, MC Tsai, T Hung, P Argani, JL Rinn, Y Wang, P Brzoska, B Kong, R Li, RB West, MJ van de Vijver, S Sukumar, HY Chang. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010; 464(7291): 1071–1076
https://doi.org/10.1038/nature08975
pmid: 20393566
|
7 |
O Wapinski, HY Chang. Long noncoding RNAs and human disease. Trends Cell Biol 2011; 21(6): 354–361
https://doi.org/10.1016/j.tcb.2011.04.001
pmid: 21550244
|
8 |
Y Liu, M Zhang, L Liang, J Li, YX Chen. Over-expression of lncRNA DANCR is associated with advanced tumor progression and poor prognosis in patients with colorectal cancer. Int J Clin Exp Pathol 2015; 8(9): 11480–11484
pmid: 26617879
|
9 |
YK Ren, Y Xiao, XB Wan, YZ Zhao, J Li, Y Li, GS Han, XB Chen, QY Zou, GC Wang, CM Lu, YC Xu, YC Wang. Association of long non-coding RNA HOTTIP with progression and prognosis in colorectal cancer. Int J Clin Exp Pathol 2015; 8(9): 11458–11463
pmid: 26617875
|
10 |
M Díaz-Beyá, S Brunet, J Nomdedéu, M Pratcorona, A Cordeiro, D Gallardo, L Escoda, M Tormo, I Heras, JM Ribera, R Duarte, MP de Llano, J Bargay, A Sampol, M Nomdedeu, RM Risueño, M Hoyos, J Sierra, M Monzo, A Navarro, J Esteve; Cooperative AML group CETLAM. The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature. Oncotarget 2015; 6(31): 31613–31627
pmid: 26436590
|
11 |
JH Joo, D Ryu, Q Peng, SP Sugrue. Role of Pnn in alternative splicing of a specific subset of lncRNAs of the corneal epithelium. Mol Vis 2014; 20: 1629–1642
pmid: 25489234
|
12 |
H Tilgner, DG Knowles, R Johnson, CA Davis, S Chakrabortty, S Djebali, J Curado, M Snyder, TR Gingeras, R Guigó. Deep sequencing of subcellular RNA fractions shows splicing to be predominantly co-transcriptional in the human genome but inefficient for lncRNAs. Genome Res 2012; 22(9): 1616–1625
https://doi.org/10.1101/gr.134445.111
pmid: 22955974
|
13 |
S Massone, I Vassallo, M Castelnuovo, G Fiorino, E Gatta, M Robello, R Borghi, M Tabaton, C Russo, G Dieci, R Cancedda, A Pagano. RNA polymerase III drives alternative splicing of the potassium channel-interacting protein contributing to brain complexity and neurodegeneration. J Cell Biol 2011; 193(5): 851–866
https://doi.org/10.1083/jcb.201011053
pmid: 21624954
|
14 |
LD Graham, SK Pedersen, GS Brown, T Ho, Z Kassir, AT Moynihan, EK Vizgoft, R Dunne, L Pimlott, GP Young, LC Lapointe, PL Molloy. Colorectal Neoplasia Differentially Expressed (CRNDE), a novel gene with elevated expression in colorectal adenomas and adenocarcinomas. Genes Cancer 2011; 2(8): 829–840
https://doi.org/10.1177/1947601911431081
pmid: 22393467
|
15 |
XL Fu, DJ Liu, TT Yan, JY Yang, MW Yang, J Li, YM Huo, W Liu, JF Zhang, J Hong, R Hua, HY Chen, YW Sun. Analysis of long non-coding RNA expression profiles in pancreatic ductal adenocarcinoma. Sci Rep 2016; 6(1): 33535
https://doi.org/10.1038/srep33535
pmid: 27628540
|
16 |
X Zhang, S Sun, JK Pu, AC Tsang, D Lee, VO Man, WM Lui, ST Wong, GK Leung. Long non-coding RNA expression profiles predict clinical phenotypes in glioma. Neurobiol Dis 2012; 48(1): 1–8
https://doi.org/10.1016/j.nbd.2012.06.004
pmid: 22709987
|
17 |
BC Ellis, PL Molloy, LD Graham. CRNDE: a long non-coding RNA involved in cancer, neurobiology, and development. Front Genet 2012; 3: 270
https://doi.org/10.3389/fgene.2012.00270
pmid: 23226159
|
18 |
P Han, JW Li, BM Zhang, JC Lv, YM Li, XY Gu, ZW Yu, YH Jia, XF Bai, L Li, YL Liu, BB Cui. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling. Mol Cancer 2017; 16(1): 9
https://doi.org/10.1186/s12943-017-0583-1
pmid: 28086904
|
19 |
K Shao, T Shi, Y Yang, X Wang, D Xu, P Zhou. Highly expressed lncRNA CRNDE promotes cell proliferation through Wnt/β-catenin signaling in renal cell carcinoma. Tumour Biol 2016; 37(12): 15997–16004
https://doi.org/10.1007/s13277-016-5440-0
pmid: 27714674
|
20 |
J Zheng, XD Li, P Wang, XB Liu, YX Xue, Y Hu, Z Li, ZQ Li, ZH Wang, YH Liu. CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186. Oncotarget 2015; 6(28): 25339–25355
https://doi.org/10.18632/oncotarget.4509
pmid: 26231038
|
21 |
T Liu, X Zhang, YM Yang, LT Du, CX Wang. Increased expression of the long noncoding RNA CRNDE-h indicates a poor prognosis in colorectal cancer, and is positively correlated with IRX5 mRNA expression. Onco Targets Ther 2016; 9: 1437–1448
pmid: 27042112
|
22 |
T Liu, X Zhang, S Gao, F Jing, Y Yang, L Du, G Zheng, P Li, C Li, C Wang. Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer. Oncotarget 2016; 7(51): 85551–85563
pmid: 27888803
|
23 |
W Berkofsky-Fessler, TQ Nguyen, P Delmar, J Molnos, C Kanwal, W DePinto, J Rosinski, P McLoughlin, S Ritland, M DeMario, K Tobon, JF Reidhaar-Olson, R Rueger, H Hilton. Preclinical biomarkers for a cyclin-dependent kinase inhibitor translate to candidate pharmacodynamic biomarkers in phase I patients. Mol Cancer Ther 2009; 8(9): 2517–2525
https://doi.org/10.1158/1535-7163.MCT-09-0083
pmid: 19755512
|
24 |
C Goujon, O Moncorgé, H Bauby, T Doyle, CC Ward, T Schaller, S Hué, WS Barclay, R Schulz, MH Malim. Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection. Nature 2013; 502(7472): 559–562
https://doi.org/10.1038/nature12542
pmid: 24048477
|
25 |
R Benito, E Lumbreras, M Abáigar, NC Gutiérrez, M Delgado, C Robledo, JL García, AE Rodríguez-Vicente, MC Cañizo, JM Rivas. Imatinib therapy of chronic myeloid leukemia restores the expression levels of key genes for DNA damage and cell-cycle progression. Pharmacogenet Genomics 2012; 22(5): 381–388
pmid: 22388797
|
26 |
BC Ellis, LD Graham, PL Molloy. CRNDE, a long non-coding RNA responsive to insulin/IGF signaling, regulates genes involved in central metabolism. Biochim Biophys Acta 2014; 1843(2): 372–386
https://doi.org/10.1016/j.bbamcr.2013.10.016
pmid: 24184209
|
27 |
A Khamas, T Ishikawa, K Shimokawa, K Mogushi, S Iida, M Ishiguro, H Mizushima, H Tanaka, H Uetake, K Sugihara. Screening for epigenetically masked genes in colorectal cancer Using 5-Aza-2′-deoxycytidine, microarray and gene expression profile. Cancer Genomics Proteomics 2012; 9(2): 67–75
pmid: 22399497
|
28 |
J Sabates-Bellver, LG Van der Flier, M de Palo, E Cattaneo, C Maake, H Rehrauer, E Laczko, MA Kurowski, JM Bujnicki, M Menigatti, J Luz, TV Ranalli, V Gomes, A Pastorelli, R Faggiani, M Anti, J Jiricny, H Clevers, G Marra. Transcriptome profile of human colorectal adenomas. Mol Cancer Res 2007; 5(12): 1263–1275
https://doi.org/10.1158/1541-7786.MCR-07-0267
pmid: 18171984
|
29 |
G Valcz, AV Patai, A Kalmár, B Péterfia, I Fűri, B Wichmann, G Műzes, F Sipos, T Krenács, E Mihály, S Spisák, B Molnár, Z Tulassay. Myofibroblast-derived SFRP1 as potential inhibitor of colorectal carcinoma field effect. PLoS One 2014; 9(11): e106143
https://doi.org/10.1371/journal.pone.0106143
pmid: 25405986
|
30 |
O Galamb, B Györffy, F Sipos, S Spisák, AM Németh, P Miheller, Z Tulassay, E Dinya, B Molnár. Inflammation, adenoma and cancer: objective classification of colon biopsy specimens with gene expression signature. Dis Markers 2008; 25(1): 1–16
https://doi.org/10.1155/2008/586721
pmid: 18776587
|
31 |
L Sun, AM Hui, Q Su, A Vortmeyer, Y Kotliarov, S Pastorino, A Passaniti, J Menon, J Walling, R Bailey, M Rosenblum, T Mikkelsen, HA Fine. Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 2006; 9(4): 287–300
https://doi.org/10.1016/j.ccr.2006.03.003
pmid: 16616334
|
32 |
MJ Demeure, KE Coan, CS Grant, RA Komorowski, E Stephan, S Sinari, D Mount, KJ Bussey. PTTG1 overexpression in adrenocortical cancer is associated with poor survival and represents a potential therapeutic target. Surgery 2013; 154(6): 1405–1416, discussion 1416
https://doi.org/10.1016/j.surg.2013.06.058
pmid: 24238056
|
33 |
TJ Giordano, R Kuick, T Else, PG Gauger, M Vinco, J Bauersfeld, D Sanders, DG Thomas, G Doherty, G Hammer. Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling. Clin Cancer Res 2009; 15(2): 668–676
https://doi.org/10.1158/1078-0432.CCR-08-1067
pmid: 19147773
|
34 |
H Pei, L Li, BL Fridley, GD Jenkins, KR Kalari, W Lingle, G Petersen, Z Lou, L Wang. FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell 2009; 16(3): 259–266
https://doi.org/10.1016/j.ccr.2009.07.016
pmid: 19732725
|
35 |
W Du, Z Cao, T Song, Y Li, Y Liang. A feature selection method based on multiple kernel learning with expression profiles of different types. BioData Min 2017; 10(1): 4
https://doi.org/10.1186/s13040-017-0124-x
pmid: 28184251
|
36 |
L Badea, V Herlea, SO Dima, T Dumitrascu, I Popescu. Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. Hepatogastroenterology 2008; 55(88): 2016–2027
pmid: 19260470
|
37 |
MS Arredouani, B Lu, M Bhasin, M Eljanne, W Yue, JM Mosquera, GJ Bubley, V Li, MA Rubin, TA Libermann, MG Sanda. Identification of the transcription factor single-minded homologue 2 as a potential biomarker and immunotherapy target in prostate cancer. Clin Cancer Res 2009; 15(18): 5794–5802
https://doi.org/10.1158/1078-0432.CCR-09-0911
pmid: 19737960
|
38 |
MM Mortensen, S Høyer, AS Lynnerup, TF Ørntoft, KD Sørensen, M Borre, L Dyrskjøt. Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy. Sci Rep 2015; 5(1): 16018
https://doi.org/10.1038/srep16018
pmid: 26522007
|
39 |
NJ Bowen, LD Walker, LV Matyunina, S Logani, KA Totten, BB Benigno, JF McDonald. Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells. BMC Med Genomics 2009; 2(1): 71
https://doi.org/10.1186/1755-8794-2-71
pmid: 20040092
|
40 |
JA den Boon, D Pyeon, SS Wang, M Horswill, M Schiffman, M Sherman, RE Zuna, Z Wang, SM Hewitt, R Pearson, M Schott, L Chung, Q He, P Lambert, J Walker, MA Newton, N Wentzensen, P Ahlquist. Molecular transitions from papillomavirus infection to cervical precancer and cancer: role of stromal estrogen receptor signaling. Proc Natl Acad Sci U S A 2015; 112(25): E3255– E3264
https://doi.org/10.1073/pnas.1509322112
pmid: 26056290
|
41 |
L Hu, J Ai, H Long, W Liu, X Wang, Y Zuo, Y Li, Q Wu, Y Deng. Integrative microRNA and gene profiling data analysis reveals novel biomarkers and mechanisms for lung cancer. Oncotarget 2016; 7(8): 8441–8454
pmid: 26870998
|
42 |
BA Jee, H Lim, SM Kwon, Y Jo, MC Park, IJ Lee, HG Woo. Molecular classification of basal cell carcinoma of skin by gene expression profiling. Mol Carcinog 2015; 54(12): 1605–1612
https://doi.org/10.1002/mc.22233
pmid: 25328065
|
43 |
YL Choi, K Tsukasaki, MC O’Neill, Y Yamada, Y Onimaru, K Matsumoto, J Ohashi, Y Yamashita, S Tsutsumi, R Kaneda, S Takada, H Aburatani, S Kamihira, T Nakamura, M Tomonaga, H Mano. A genomic analysis of adult T-cell leukemia. Oncogene 2007; 26(8): 1245–1255
https://doi.org/10.1038/sj.onc.1209898
pmid: 16909099
|
44 |
JE Payton, NR Grieselhuber, LW Chang, M Murakami, GK Geiss, DC Link, R Nagarajan, MA Watson, TJ Ley. High throughput digital quantification of mRNA abundance in primary human acute myeloid leukemia samples. J Clin Invest 2009; 119(6): 1714–1726
https://doi.org/10.1172/JCI38248
pmid: 19451695
|
45 |
A Kohlmann, TJ Kipps, LZ Rassenti, JR Downing, SA Shurtleff, KI Mills, AF Gilkes, WK Hofmann, G Basso, MC Dell’orto, R Foà, S Chiaretti, J De Vos, S Rauhut, PR Papenhausen, JM Hernández, E Lumbreras, AE Yeoh, ES Koay, R Li, WM Liu, PM Williams, L Wieczorek, T Haferlach. An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in Leukemia Study Prephase. Br J Haematol 2008; 142(5): 802–807
https://doi.org/10.1111/j.1365-2141.2008.07261.x
pmid: 18573112
|
46 |
T Haferlach, A Kohlmann, L Wieczorek, G Basso, GT Kronnie, MC Béné, J De Vos, JM Hernández, WK Hofmann, KI Mills, A Gilkes, S Chiaretti, SA Shurtleff, TJ Kipps, LZ Rassenti, AE Yeoh, PR Papenhausen, WM Liu, PM Williams, R Foà. Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group. J Clin Oncol 2010; 28(15): 2529–2537
https://doi.org/10.1200/JCO.2009.23.4732
pmid: 20406941
|
47 |
K Filarsky, A Garding, N Becker, C Wolf, M Zucknick, R Claus, D Weichenhan, C Plass, H Döhner, S Stilgenbauer, P Lichter, D Mertens. Krüppel-like factor 4 (KLF4) inactivation in chronic lymphocytic leukemia correlates with promoter DNA-methylation and can be reversed by inhibition of NOTCH signaling. Haematologica 2016; 101(6): e249–e253
https://doi.org/10.3324/haematol.2015.138172
pmid: 27081174
|
48 |
XJ Chu, W DePinto, D Bartkovitz, SS So, BT Vu, K Packman, C Lukacs, Q Ding, N Jiang, K Wang, P Goelzer, X Yin, MA Smith, BX Higgins, Y Chen, Q Xiang, J Moliterni, G Kaplan, B Graves, A Lovey, N Fotouhi. Discovery of [4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,3-difluoro-6- methoxyphenyl)methanone (R547), a potent and selective cyclin-dependent kinase inhibitor with significant in vivo antitumor activity. J Med Chem 2006; 49(22): 6549–6560
https://doi.org/10.1021/jm0606138
pmid: 17064073
|
49 |
A Myrthue, BL Rademacher, J Pittsenbarger, B Kutyba-Brooks, M Gantner, DZ Qian, TM Beer. The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells. Clin Cancer Res 2008; 14(11): 3562–3570
https://doi.org/10.1158/1078-0432.CCR-07-4649
pmid: 18519790
|
50 |
LM Szafron, A Balcerak, EA Grzybowska, B Pienkowska-Grela, A Podgorska, R Zub, M Olbryt, J Pamula-Pilat, KM Lisowska, E Grzybowska, T Rubel, A Dansonka-Mieszkowska, B Konopka, M Kulesza, M Lukasik, J Kupryjanczyk. The putative oncogene, CRNDE, is a negative prognostic factor in ovarian cancer patients. Oncotarget 2015; 6(41): 43897–43910
pmid: 26556866
|
51 |
Y Wang, Y Wang, J Li, Y Zhang, H Yin, B Han. CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling. Cancer Lett 2015; 367(2): 122–128
https://doi.org/10.1016/j.canlet.2015.03.027
pmid: 25813405
|
52 |
J Zheng, X Liu, P Wang, Y Xue, J Ma, C Qu, Y Liu. CRNDE promotes malignant progression of glioma by attenuating miR-384/PIWIL4/STAT3 axis. Mol Ther 2016; 24(7): 1199–1215
https://doi.org/10.1038/mt.2016.71
pmid: 27058823
|
53 |
H Gao, X Song, T Kang, B Yan, L Feng, L Gao, L Ai, X Liu, J Yu, H Li. Long noncoding RNA CRNDE functions as a competing endogenous RNA to promote metastasis and oxaliplatin resistance by sponging miR-136 in colorectal cancer. Onco Targets Ther 2017; 10: 205–216
https://doi.org/10.2147/OTT.S116178
pmid: 28115855
|
54 |
AM Khalil, M Guttman, M Huarte, M Garber, A Raj, D Rivea Morales, K Thomas, A Presser, BE Bernstein, A van Oudenaarden, A Regev, ES Lander, JL Rinn. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A 2009; 106(28): 11667–11672
https://doi.org/10.1073/pnas.0904715106
pmid: 19571010
|
55 |
LM Szafron, A Balcerak, EA Grzybowska, B Pienkowska-Grela, A Felisiak-Golabek, A Podgorska, M Kulesza, N Nowak, P Pomorski, J Wysocki, T Rubel, A Dansonka-Mieszkowska, B Konopka, M Lukasik, J Kupryjanczyk. The novel gene CRNDE encodes a nuclear peptide (CRNDEP) which is overexpressed in highly proliferating tissues. PLoS One 2015; 10(5): e0127475
https://doi.org/10.1371/journal.pone.0127475
pmid: 25978564
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|